(R)-2-hydroxyglutarate inhibits KDM5 histone lysine demethylases to drive tumorigenesis in IDH-mutant cancers. Gunn et al.

Published: 20 December 2021| Version 1 | DOI: 10.17632/mrwhkxynpb.1
Contributor:
Kathryn Gunn

Description

Western blots and microscopy

Files

Institutions

Dana Farber Cancer Institute

Categories

Acute Myelogenous Leukemia, Glioma

Licence